Resveratrol is a potent inhibitor of vascularization and cell proliferation in experimental endometriosis.
about
Self-management and psychological-sexological interventions in patients with endometriosis: strategies, outcomes, and integration into clinical careEffect of induced peritoneal endometriosis on oocyte and embryo quality in a mouse model.Vascular endothelial growth factor receptor-2 inhibitor cediranib causes regression of endometriotic lesions in a rat modelLuminal epithelium in endometrial fragments affects their vascularization, growth and morphological development into endometriosis-like lesions in mice.The complementary and alternative medicine for endometriosis: a review of utilization and mechanism.Resveratrol Reduces Myometrial Infiltration, Uterine Hyperactivity, and Stress Levels and Alleviates Generalized Hyperalgesia in Mice With Induced Adenomyosis.Targeting oxidative stress to treat endometriosis.Kinase signalling pathways in endometriosis: potential targets for non-hormonal therapeutics.Extracellular NAMPT/visfatin causes p53 deacetylation via NAD production and SIRT1 activation in breast cancer cells.Combination therapy with telmisartan and parecoxib induces regression of endometriotic lesions.Combined blockade of angiotensin II type 1 receptor and activation of peroxisome proliferator-activated receptor-γ by telmisartan effectively inhibits vascularization and growth of murine endometriosis-like lesions.The Use of Resveratrol as an Adjuvant Treatment of Pain in Endometriosis: A Randomized Clinical Trial.Resveratrol Enhances Apoptosis in Endometriotic Stromal Cells.Analysis of the efficacy of resveratrol treatment in patients with scarred uterus.
P2860
Q33650501-1223A25F-4150-4C9C-AE91-78A3BE751E4EQ35160916-3BACD8EE-9E62-4F04-ABCD-3E9FE817FD15Q35406146-FFA61EBB-7E9E-40F7-BE4E-BE93B1CE75D6Q37566114-983BE382-6256-4B44-B3FF-858ED9491006Q37631269-61E6418D-C18D-4863-9297-8CDB681CF413Q38300910-F278A6CD-E611-456C-A145-199A5E4C0A7CQ38563499-2079E142-DD42-410F-A5A7-28FCEEA785C7Q38689176-D1EB95D2-0A03-4F08-BE91-4017592E867DQ47898447-0D87E039-A162-4031-94FE-D5BDC693334AQ48370696-6E083CA5-433E-4D5E-9BC2-4BD25C542EBFQ51157373-648242FA-F404-4514-A047-45EA328D3511Q51771265-FDB4E18F-E2C0-4297-A405-A9FB4C611EB1Q53204381-565B38AA-1E34-4F76-AC1A-8D2A0ADE6FF3Q55227525-5B450C60-D7BA-4064-AEDF-88E6345A442E
P2860
Resveratrol is a potent inhibitor of vascularization and cell proliferation in experimental endometriosis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Resveratrol is a potent inhibi ...... in experimental endometriosis.
@en
Resveratrol is a potent inhibi ...... in experimental endometriosis.
@nl
type
label
Resveratrol is a potent inhibi ...... in experimental endometriosis.
@en
Resveratrol is a potent inhibi ...... in experimental endometriosis.
@nl
prefLabel
Resveratrol is a potent inhibi ...... in experimental endometriosis.
@en
Resveratrol is a potent inhibi ...... in experimental endometriosis.
@nl
P2093
P2860
P356
P1433
P1476
Resveratrol is a potent inhibi ...... in experimental endometriosis.
@en
P2093
J Rudzitis-Auth
M D Menger
M W Laschke
P2860
P304
P356
10.1093/HUMREP/DET031
P407
P577
2013-02-20T00:00:00Z